3-20183961-T-C
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 8P and 1B. PP5_Very_StrongBS2_Supporting
The NM_001199251.3(SGO1):βc.67A>Gβ(p.Lys23Glu) variant causes a missense change. The variant allele was found at a frequency of 0.000164 in 1,612,714 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (β β ).
Frequency
Genomes: π 0.00014 ( 0 hom., cov: 33)
Exomes π: 0.00017 ( 0 hom. )
Consequence
SGO1
NM_001199251.3 missense
NM_001199251.3 missense
Scores
6
9
3
Clinical Significance
Conservation
PhyloP100: 6.24
Genes affected
SGO1 (HGNC:25088): (shugoshin 1) The protein encoded by this gene is a member of the shugoshin family of proteins. This protein is thought to protect centromeric cohesin from cleavage during mitotic prophase by preventing phosphorylation of a cohesin subunit. Reduced expression of this gene leads to the premature loss of centromeric cohesion, mis-segregation of sister chromatids, and mitotic arrest. Evidence suggests that this protein also protects a small subset of cohesin found along the length of the chromosome arms during mitotic prophase. An isoform lacking exon 6 has been shown to play a role in the cohesion of centrioles (PMID: 16582621 and PMID:18331714). Mutations in this gene have been associated with Chronic Atrial and Intestinal Dysrhythmia (CAID) syndrome, characterized by the co-occurrence of Sick Sinus Syndrome (SSS) and Chronic Intestinal Pseudo-obstruction (CIPO) within the first four decades of life (PMID:25282101). Fibroblast cells from CAID patients exhibited both increased cell proliferation and higher rates of senescence. Pseudogenes of this gene have been found on chromosomes 1 and 7. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
PP5
Variant 3-20183961-T-C is Pathogenic according to our data. Variant chr3-20183961-T-C is described in ClinVar as [Pathogenic]. Clinvar id is 162627.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-20183961-T-C is described in Lovd as [Pathogenic].
BS2
High AC in GnomAd4 at 21 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SGO1 | NM_001199251.3 | c.67A>G | p.Lys23Glu | missense_variant | 2/8 | ENST00000412997.6 | NP_001186180.1 | |
SGO1-AS1 | NR_132785.1 | n.359-2014T>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SGO1 | ENST00000412997.6 | c.67A>G | p.Lys23Glu | missense_variant | 2/8 | 1 | NM_001199251.3 | ENSP00000410458 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152234Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
21
AN:
152234
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000188 AC: 47AN: 250128Hom.: 0 AF XY: 0.000192 AC XY: 26AN XY: 135160
GnomAD3 exomes
AF:
AC:
47
AN:
250128
Hom.:
AF XY:
AC XY:
26
AN XY:
135160
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000167 AC: 244AN: 1460480Hom.: 0 Cov.: 31 AF XY: 0.000154 AC XY: 112AN XY: 726440
GnomAD4 exome
AF:
AC:
244
AN:
1460480
Hom.:
Cov.:
31
AF XY:
AC XY:
112
AN XY:
726440
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000138 AC: 21AN: 152234Hom.: 0 Cov.: 33 AF XY: 0.000148 AC XY: 11AN XY: 74370
GnomAD4 genome
AF:
AC:
21
AN:
152234
Hom.:
Cov.:
33
AF XY:
AC XY:
11
AN XY:
74370
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
22
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Chronic atrial and intestinal dysrhythmia Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Neuberg Centre For Genomic Medicine, NCGM | - | The missense c.67A>G p.Lys23Glu variant in SGO1 gene has been reported in homozygous state in multiple individuals affected with gastrointestinal disorder Chetaille et al., 2014. In vitro studies in patient fibroblasts with homozygous p.Lys23Glu suggest abnormal cell progression, cell signalling, epigenetic modifications, and protein expression compared to controls Chetaille et al., 2014. The variant is reported with allele frequency of 0.02% in gnomAD Exomes and is novel not in any individuals in 1000 Genomes. This variant has been reported to the ClinVar database as Pathogenic multiple submissions. The amino acid change p.Lys23Glu in SGO1 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. The amino acid Lys at position 23 is changed to a Glu changing protein sequence and it might alter its composition and physico-chemical properties. For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 01, 2014 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Apr 12, 2022 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jan 11, 2023 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; In vitro studies in patient fibroblasts with homozygous p.K23E suggest abnormal cell progression, cell signalling, epigenetic modifications, and protein expression compared to controls (Chetaille et al., 2014; Piche et al., 2019); This variant is associated with the following publications: (PMID: 31516082, 30739867, 25282101, 35799243, 32213217, 33953173) - |
SGO1-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 01, 2024 | The SGO1 c.67A>G variant is predicted to result in the amino acid substitution p.Lys23Glu. This missense change has been documented in the homozygous state in multiple unrelated individuals with chronic atrial and intestinal dysrhythmia, and functional studies support its pathogenicity (Chetaille et al 2014. PubMed ID: 25282101; PichΓ© et al. 2019. PubMed ID: 30739867). This variant is reported in 0.031% of alleles in individuals of Latino descent in gnomAD. This variant is interpreted as likely pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
.;.;D;.;.;D;.;.;.;.;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
.;.;.;T;T;T;T;T;T;.;T
M_CAP
Uncertain
D
MetaRNN
Uncertain
D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Uncertain
T
MutationTaster
Benign
D;D;D;D;D;D;D;D;D;D;D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;D;D;D;D;D;D;D;D;D
REVEL
Pathogenic
Sift
Uncertain
D;D;D;D;D;D;D;D;D;D;D
Sift4G
Pathogenic
D;D;D;D;D;D;D;D;D;D;D
Polyphen
D;D;D;D;D;D;D;D;.;D;D
Vest4
MVP
MPC
0.19
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at